AU6080294A - Antisense molecules directed against genes of the (raf) oncogene family - Google Patents
Antisense molecules directed against genes of the (raf) oncogene familyInfo
- Publication number
- AU6080294A AU6080294A AU60802/94A AU6080294A AU6080294A AU 6080294 A AU6080294 A AU 6080294A AU 60802/94 A AU60802/94 A AU 60802/94A AU 6080294 A AU6080294 A AU 6080294A AU 6080294 A AU6080294 A AU 6080294A
- Authority
- AU
- Australia
- Prior art keywords
- raf
- directed against
- antisense molecules
- oncogene family
- molecules directed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99971092A | 1992-12-31 | 1992-12-31 | |
US999710 | 1992-12-31 | ||
PCT/US1993/012603 WO1994015645A1 (en) | 1992-12-31 | 1993-12-28 | Antisense molecules directed against genes of the raf oncogene family |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6080294A true AU6080294A (en) | 1994-08-15 |
Family
ID=25546620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU60802/94A Abandoned AU6080294A (en) | 1992-12-31 | 1993-12-28 | Antisense molecules directed against genes of the (raf) oncogene family |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU6080294A (en) |
WO (1) | WO1994015645A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU689267B2 (en) * | 1994-05-31 | 1998-03-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of RAF gene expression |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU220969B1 (en) * | 1993-01-07 | 2002-07-29 | Thomas Jefferson University | Use of c-myc specific antisense oligonucleotide to modulate the proliferation of smooth muscle cells |
US6323184B1 (en) | 1993-10-15 | 2001-11-27 | Thomas Jefferson University | Arteriovenous and venous graft treatments: methods and compositions |
US6133242A (en) * | 1993-10-15 | 2000-10-17 | Thomas Jefferson Univerisity | Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
US5656612A (en) * | 1994-05-31 | 1997-08-12 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US6358932B1 (en) | 1994-05-31 | 2002-03-19 | Isis Pharmaceticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
US5744362A (en) * | 1994-05-31 | 1998-04-28 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of raf gene expression |
US6410518B1 (en) | 1994-05-31 | 2002-06-25 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of raf gene expression |
US6090626A (en) * | 1994-05-31 | 2000-07-18 | Isis Pharmaceuticals Inc. | Antisense oligonucleotide modulation of raf gene expression |
KR100211178B1 (en) * | 1994-05-31 | 1999-07-15 | 파샬 비. 린네 | Antisense oligonucleotide modulation of raf gene expression |
US5744460A (en) * | 1996-03-07 | 1998-04-28 | Novartis Corporation | Combination for treatment of proliferative diseases |
AU2092597A (en) * | 1996-03-07 | 1997-09-22 | Novartis Ag | Antiproliferative combinations, containing raf-targeted oligonucleotides and chemotherapeutic compounds |
US6803360B1 (en) | 1996-12-30 | 2004-10-12 | Georgetown University | Compositions and methods for reducing radiation and drug resistance in cells |
US7262173B2 (en) | 1997-03-21 | 2007-08-28 | Georgetown University | Chemosensitizing with liposomes containing oligonucleotides |
WO2000064422A2 (en) * | 1999-04-27 | 2000-11-02 | Smithkline Beecham P.L.C. | Novel treatment of neurotraumatic conditions with raf inhibitor |
PT2796553T (en) | 2000-03-30 | 2019-09-27 | Massachusetts Inst Technology | Rna sequence-specific mediators of rna interference |
DE10020138A1 (en) * | 2000-04-14 | 2001-10-31 | Ulf R Rapp | Nucleic acid coding for at least one partial sequence with a MEKK1 binding site |
WO2002044321A2 (en) | 2000-12-01 | 2002-06-06 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Rna interference mediating small rna molecules |
AU2002303261A1 (en) | 2001-04-06 | 2002-10-21 | Georgetown University | Gene brcc2 and diagnostic and therapeutic uses thereof |
AU2002258728A1 (en) | 2001-04-06 | 2002-10-21 | Georgetown University | Gene brcc-3 and diagnostic and therapeutic uses thereof |
AU2002305151A1 (en) | 2001-04-06 | 2002-10-21 | Georgetown University | Gene scc-112 and diagnostic and therapeutic uses thereof |
US7244565B2 (en) | 2002-04-10 | 2007-07-17 | Georgetown University | Gene shinc-3 and diagnostic and therapeutic uses thereof |
AU2003228238A1 (en) * | 2002-05-20 | 2003-12-12 | Neopharm, Inc. | Method for reducing platelet count |
-
1993
- 1993-12-28 WO PCT/US1993/012603 patent/WO1994015645A1/en active Application Filing
- 1993-12-28 AU AU60802/94A patent/AU6080294A/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU689267B2 (en) * | 1994-05-31 | 1998-03-26 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of RAF gene expression |
Also Published As
Publication number | Publication date |
---|---|
WO1994015645A1 (en) | 1994-07-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6080294A (en) | Antisense molecules directed against genes of the (raf) oncogene family | |
AU4794593A (en) | Antisense viruses and antisense-ribozyme viruses | |
AU2417895A (en) | Genes for the synthesis of antipathogenic substances | |
GB9210273D0 (en) | Dna | |
AU1768192A (en) | Rna delivery vector | |
AU8260491A (en) | Dna sequencing | |
AU7767787A (en) | Polyamine-polyene ultraviolet coatings | |
AU5568694A (en) | Stable oligonucleotides | |
EP0754187A4 (en) | Growth arrest homeobox gene | |
EP0781326A4 (en) | The irs family of genes | |
AU2351492A (en) | Process for the preparation of middle distillates | |
AU2880392A (en) | Chromatographic separation of phosphorothioate oligonucleotides | |
AU6601690A (en) | Selective inhibition of gene expression by photoactivatable oligonucleotides | |
AU5590394A (en) | Transglutaminase gene | |
AU639339B2 (en) | Improved coatings | |
AU3730093A (en) | Methods of treating diabetes | |
AU3729493A (en) | Cyclobutyl antisense oligonucleotides, methods of making and use thereof | |
AU3402793A (en) | Imidazolyl-substituted phenylacetamides | |
AU3710593A (en) | Sulphonylated carboxamides | |
AU4744893A (en) | Sample core stabilization | |
HU9500979D0 (en) | Antisense oligonucleotide inhibition of the ras gene | |
AU2356197A (en) | Weirs | |
AU2285592A (en) | Improved coating solution | |
AU3462193A (en) | Polyalkylcyanoacrylate nanocapsules | |
AU5371694A (en) | Use of the tarchonanthus camphoratus |